NeuFluent, a neuroscience innovation venture studio, has launched a new “intelligent implants and robotics initiative”.
The move expands its work in next-generation surgical innovations and broadens its technology portfolio that includes brain-computer interface and pharmaceutical technology.
NeuFluent partners with leading innovators to accelerate neurological technologies from concept to market, with a track record that includes more than 110 commercialized products, over 250 patents, 25 exits, and a total return on investment of more than $20 billion. [Read more…] about NeuFluent expands innovation ecosystem with new intelligent implants and robotics initiative









